Wholesale of pharmaceutical and medical goods
RETHINK PHARMA AS
Revenue 2024
NOK 495
Operating profit
NOK −1,000
Equity
NOK −275,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2024
Current ratio
0.77
Equity ratio
-63.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -226.3% | |
| Net margin (%%) | -236.6% | |
| Return on assets (%%) | -0.3% | |
| Likviditet | ||
| Current ratio | 0.77 | |
| Working capital | −126k | |
| Soliditet | ||
| Equity ratio (%%) | -63.7% | |
| Debt-to-equity ratio | -2.57 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.